Singla Nitika, Garg Kamakshi, Jain Richa, Malhotra Aaina, Singh Mirley Rupinder, Grewal Anju
Department of Anaesthesiology, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.
Department of Anaesthesiology and Critical Care, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
Indian J Anaesth. 2021 Sep;65(Suppl 3):S121-S126. doi: 10.4103/ija.IJA_228_21. Epub 2021 Sep 15.
Transversus abdominis plane (TAP) block is commonly used to treat post-operative pain after lower abdominal surgeries. The aim of this randomised controlled study was to assess the efficacy of addition of dexmedetomidine or dexamethasone to ropivacaine in TAP block and compare the two for post-operative pain relief in caesarean section.
A hundred parturients (18-45 years) undergoing caesarean section under spinal anaesthesia received ultrasound-guided (USG) bilateral TAP block with 50ml of 3mg/kg ropivacaine along with 0.1mg/kg dexamethasone (Group A) or 1μg/kg dexmedetomidine (Group B) in this prospective, randomised, double-blind study. Time to initial self-reporting of post-operative pain, time to first rescue analgesic demand, visual analogue scale (VAS) for pain haemodynamic parameters and adverse effects if any were noted, anda value < 0.005 was considered as statistically significant.
Time to initial self-reporting of post-operative pain (411.35 vs. 338.20 min, < 0.005) and time to first rescue analgesic (474.30 vs. 407.30 min, < 0.005) were significantly longer in group B as compared to group A. VAS score at the time of initial self-reporting of pain was significantly lower in group B. No significant haemodynamic changes or side-effects were noted.
Addition of dexmedetomidine to ropivacaine as compared with dexamethasone in bilateral TAP block following caesarean section prolongs the time to initial post-operative pain and time to first rescue analgesic consumption.
腹横肌平面(TAP)阻滞常用于治疗下腹部手术后的疼痛。本随机对照研究的目的是评估在TAP阻滞中,于罗哌卡因中添加右美托咪定或地塞米松的疗效,并比较两者在剖宫产术后疼痛缓解方面的效果。
在这项前瞻性、随机、双盲研究中,100名(18 - 45岁)接受腰麻下行剖宫产的产妇接受了超声引导(USG)双侧TAP阻滞,其中50ml 3mg/kg罗哌卡因联合0.1mg/kg地塞米松(A组)或1μg/kg右美托咪定(B组)。记录术后首次自我报告疼痛的时间、首次需要补救镇痛的时间、疼痛视觉模拟评分(VAS)、血流动力学参数以及是否有不良反应,P值<0.005被认为具有统计学意义。
与A组相比,B组术后首次自我报告疼痛的时间(411.35 vs. 338.20分钟,P<0.005)和首次需要补救镇痛的时间(474.30 vs. 407.30分钟,P<0.005)显著延长。B组在首次自我报告疼痛时的VAS评分显著更低。未观察到显著的血流动力学变化或副作用。
剖宫产术后双侧TAP阻滞中,与地塞米松相比,在罗哌卡因中添加右美托咪定可延长术后首次疼痛时间和首次补救镇痛的用药时间。